Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation | stella

Back to Parkinson Disease trials

Recruiting

Plain-English translation of NCT07642908 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Read our Parkinson Disease research guide →

Trial locations(1 site)

United States

University of Michigan, Ann Arbor, Michigan

Key details

Sponsor

University of Michigan

Collaborators

Michael J. Fox Foundation for Parkinson's Research

Enrollment target

~15 participants

Started

September 2025

Primary completion

September 2026

Age range

45 Years and older

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Nathan Alexander, BSc

University of Michigan

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.